<DOC>
	<DOCNO>NCT00129285</DOCNO>
	<brief_summary>Despite year active research , still approve medication treatment cocaine dependence . The purpose study determine effectiveness modafinil treat cocaine-dependent individual .</brief_summary>
	<brief_title>Modafinil Treatment Cocaine-Dependent Individuals</brief_title>
	<detailed_description>Modafinil glutamate-enhancing agent blunts cocaine euphoria control condition . Due stimulant-like property , modafinil also likely relieve severe cocaine withdrawal symptom . In turn , may lead good clinical outcome . The purpose study determine whether modafinil improve abstinence early recovery cocaine dependence . This 6-month , double-blind , placebo-controlled trial enroll 210 participant current DSM-IV diagnosis cocaine dependence . Treatment occur 8 week . Participants randomly assign receive single morning dose low-dose modafinil ( 200 mg/day ) , high-dose modafinil ( 400 mg/day ) , match placebo tablet . In addition , week participant receive manual-guided cognitive behavioral therapy Treatment Research Center . At end 8-week treatment period , modafinil placebo abruptly discontinue . One week following , end medication evaluation occur . In addition , two follow-up evaluation take place 3 5 month initial randomization . Efforts make continue evaluation subject decide discontinue modafinil treatment . Urine benzoylecgonine level use measure cocaine abstinence . Craving , withdrawal , retention , adverse event also evaluate .</detailed_description>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Modafinil</mesh_term>
	<mesh_term>Armodafinil</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Male female , age 18 60 year ; Current DSMIV diagnosis cocaine dependence Using least $ 200 worth cocaine within past 30 day positive urine toxicology ( BE ) screening ; Able provide write informed consent comply study procedure ; Women must surgically sterile , least two year postmenopausal , childbearing potential use medically accept method birth control agree continue use method least 30 day last dose study drug ( i.e . barrier method spermicide , steroidal contraceptive [ oral implant , include DepoProvera contraceptive must use conjunction barrier method ] , intrauterine device [ IUD ] ) Currently dependent substance cocaine nicotine Neurological psychiatric disorder , psychosis , bipolar illness , organic brain disease , dementia , diseases require psychotropic medication Serious medical illness , include limit ; uncontrolled hypertension , significant heart disease ( include history myocardial infarction , angina , mitral valve prolapse , leave ventricular hypertrophy , palpitation , arrhythmia ) , hepatic disease , renal disease , serious , potentially lifethreatening progressive medical illness may compromise patient safety study conduct ; Received drug know potential toxicity major organ system within month prior enter treatment include limit ; chemotherapeutic agent neoplastic disease ( i.e . methotrexate , vincristine , vinblastine , fluorouracil ) , agent use parasitic infection , isoniazid , chlorambucil , dactinomycin , chloramphenicol , immunosuppressive cytotoxic agent ( i.e . cyclosporine , tacrolimus ) , indomethacin , protease inhibitor , amphotericin B , cephalosporins , aminoglycosides , interferon , sulfonamide ; Clinically significant abnormal laboratory value Has disease gastrointestinal system , liver , kidney could result altered metabolism excretion study medication ( history major gastrointestinal tract surgery , gastrectomy , gastrostomy , bowel resection , etc . ) history chronic gastrointestinal disorder ( ulcerative colitis , regional enteritis , gastrointestinal bleeding ) ; Known hypersensitivity allergy modafinil receive chronic therapy medication could interact adversely one medication study , include propranolol , phenytoin , warfarin diazepam ; Currently take medication could interact adversely one medication study , include propranolol , phenytoin , warfarin diazepam Took monoamine oxidase inhibitor ( MAOI ) within 30 day prior randomization ; Taking take investigational drug within 60 day prior enrollment If female childbearing capacity , test positive urine pregnancy test , lactating , three day amenorrhea beyond expect menses time first dose study medication , contemplate pregnancy next 6 month , use effective contraceptive method ; Received therapy opiatesubstitute ( methadone , LAAM , buprenorphine ) within 60 day study enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>June 2012</verification_date>
	<keyword>cocaine</keyword>
</DOC>